The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Speech Biomarkers Market Research Report 2024
Synopsis
Speech biomarkers are techniques for identifying diseases by the rhythm, frequency, pitch, and breathing of human voices
Global Speech Biomarkers market is projected to reach US$ 1069.9 million in 2029, increasing from US$ 520 million in 2022, with the CAGR of 11.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Speech Biomarkers market research.
Key companies engaged in the Speech Biomarkers industry include Boston Technology Corp., Cogito Corp., IBM Corp., conversation HEALTH Group, Winterlight Labs Inc., Vocalis Health, Inc., Mayo Clinic Inc., Medical Information Technology, Inc. and Sonde Health, Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Speech Biomarkers were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Speech Biomarkers market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Speech Biomarkers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Boston Technology Corp.
Cogito Corp.
IBM Corp.
conversation HEALTH Group
Winterlight Labs Inc.
Vocalis Health, Inc.
Mayo Clinic Inc.
Medical Information Technology, Inc.
Sonde Health, Inc.
PureTech Health Plc
Orbita Inc.
MediTECH Electronic GmbH
Kintsugi Mindful Wellness
Ellipsis Health
Winter Light Labs
Voice Health Tech
Segment by Type
Frequency
Amplitude
Error Rate
Pronunciation Time
Segment by Application
Mental Disorder
Respiratory Failure
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Speech Biomarkers report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Speech biomarkers are techniques for identifying diseases by the rhythm, frequency, pitch, and breathing of human voices
Global Speech Biomarkers market is projected to reach US$ 1069.9 million in 2029, increasing from US$ 520 million in 2022, with the CAGR of 11.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Speech Biomarkers market research.
Key companies engaged in the Speech Biomarkers industry include Boston Technology Corp., Cogito Corp., IBM Corp., conversation HEALTH Group, Winterlight Labs Inc., Vocalis Health, Inc., Mayo Clinic Inc., Medical Information Technology, Inc. and Sonde Health, Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Speech Biomarkers were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Speech Biomarkers market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Speech Biomarkers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Boston Technology Corp.
Cogito Corp.
IBM Corp.
conversation HEALTH Group
Winterlight Labs Inc.
Vocalis Health, Inc.
Mayo Clinic Inc.
Medical Information Technology, Inc.
Sonde Health, Inc.
PureTech Health Plc
Orbita Inc.
MediTECH Electronic GmbH
Kintsugi Mindful Wellness
Ellipsis Health
Winter Light Labs
Voice Health Tech
Segment by Type
Frequency
Amplitude
Error Rate
Pronunciation Time
Segment by Application
Mental Disorder
Respiratory Failure
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Speech Biomarkers report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Speech Biomarkers Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Frequency
1.2.3 Amplitude
1.2.4 Error Rate
1.2.5 Pronunciation Time
1.3 Market by Application
1.3.1 Global Speech Biomarkers Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Mental Disorder
1.3.3 Respiratory Failure
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Speech Biomarkers Market Perspective (2018-2029)
2.2 Speech Biomarkers Growth Trends by Region
2.2.1 Global Speech Biomarkers Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Speech Biomarkers Historic Market Size by Region (2018-2023)
2.2.3 Speech Biomarkers Forecasted Market Size by Region (2024-2029)
2.3 Speech Biomarkers Market Dynamics
2.3.1 Speech Biomarkers Industry Trends
2.3.2 Speech Biomarkers Market Drivers
2.3.3 Speech Biomarkers Market Challenges
2.3.4 Speech Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Speech Biomarkers Players by Revenue
3.1.1 Global Top Speech Biomarkers Players by Revenue (2018-2023)
3.1.2 Global Speech Biomarkers Revenue Market Share by Players (2018-2023)
3.2 Global Speech Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Speech Biomarkers Revenue
3.4 Global Speech Biomarkers Market Concentration Ratio
3.4.1 Global Speech Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Speech Biomarkers Revenue in 2022
3.5 Speech Biomarkers Key Players Head office and Area Served
3.6 Key Players Speech Biomarkers Product Solution and Service
3.7 Date of Enter into Speech Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Speech Biomarkers Breakdown Data by Type
4.1 Global Speech Biomarkers Historic Market Size by Type (2018-2023)
4.2 Global Speech Biomarkers Forecasted Market Size by Type (2024-2029)
5 Speech Biomarkers Breakdown Data by Application
5.1 Global Speech Biomarkers Historic Market Size by Application (2018-2023)
5.2 Global Speech Biomarkers Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Speech Biomarkers Market Size (2018-2029)
6.2 North America Speech Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Speech Biomarkers Market Size by Country (2018-2023)
6.4 North America Speech Biomarkers Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Speech Biomarkers Market Size (2018-2029)
7.2 Europe Speech Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Speech Biomarkers Market Size by Country (2018-2023)
7.4 Europe Speech Biomarkers Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Speech Biomarkers Market Size (2018-2029)
8.2 Asia-Pacific Speech Biomarkers Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Speech Biomarkers Market Size by Region (2018-2023)
8.4 Asia-Pacific Speech Biomarkers Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Speech Biomarkers Market Size (2018-2029)
9.2 Latin America Speech Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Speech Biomarkers Market Size by Country (2018-2023)
9.4 Latin America Speech Biomarkers Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Speech Biomarkers Market Size (2018-2029)
10.2 Middle East & Africa Speech Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Speech Biomarkers Market Size by Country (2018-2023)
10.4 Middle East & Africa Speech Biomarkers Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boston Technology Corp.
11.1.1 Boston Technology Corp. Company Detail
11.1.2 Boston Technology Corp. Business Overview
11.1.3 Boston Technology Corp. Speech Biomarkers Introduction
11.1.4 Boston Technology Corp. Revenue in Speech Biomarkers Business (2018-2023)
11.1.5 Boston Technology Corp. Recent Development
11.2 Cogito Corp.
11.2.1 Cogito Corp. Company Detail
11.2.2 Cogito Corp. Business Overview
11.2.3 Cogito Corp. Speech Biomarkers Introduction
11.2.4 Cogito Corp. Revenue in Speech Biomarkers Business (2018-2023)
11.2.5 Cogito Corp. Recent Development
11.3 IBM Corp.
11.3.1 IBM Corp. Company Detail
11.3.2 IBM Corp. Business Overview
11.3.3 IBM Corp. Speech Biomarkers Introduction
11.3.4 IBM Corp. Revenue in Speech Biomarkers Business (2018-2023)
11.3.5 IBM Corp. Recent Development
11.4 conversation HEALTH Group
11.4.1 conversation HEALTH Group Company Detail
11.4.2 conversation HEALTH Group Business Overview
11.4.3 conversation HEALTH Group Speech Biomarkers Introduction
11.4.4 conversation HEALTH Group Revenue in Speech Biomarkers Business (2018-2023)
11.4.5 conversation HEALTH Group Recent Development
11.5 Winterlight Labs Inc.
11.5.1 Winterlight Labs Inc. Company Detail
11.5.2 Winterlight Labs Inc. Business Overview
11.5.3 Winterlight Labs Inc. Speech Biomarkers Introduction
11.5.4 Winterlight Labs Inc. Revenue in Speech Biomarkers Business (2018-2023)
11.5.5 Winterlight Labs Inc. Recent Development
11.6 Vocalis Health, Inc.
11.6.1 Vocalis Health, Inc. Company Detail
11.6.2 Vocalis Health, Inc. Business Overview
11.6.3 Vocalis Health, Inc. Speech Biomarkers Introduction
11.6.4 Vocalis Health, Inc. Revenue in Speech Biomarkers Business (2018-2023)
11.6.5 Vocalis Health, Inc. Recent Development
11.7 Mayo Clinic Inc.
11.7.1 Mayo Clinic Inc. Company Detail
11.7.2 Mayo Clinic Inc. Business Overview
11.7.3 Mayo Clinic Inc. Speech Biomarkers Introduction
11.7.4 Mayo Clinic Inc. Revenue in Speech Biomarkers Business (2018-2023)
11.7.5 Mayo Clinic Inc. Recent Development
11.8 Medical Information Technology, Inc.
11.8.1 Medical Information Technology, Inc. Company Detail
11.8.2 Medical Information Technology, Inc. Business Overview
11.8.3 Medical Information Technology, Inc. Speech Biomarkers Introduction
11.8.4 Medical Information Technology, Inc. Revenue in Speech Biomarkers Business (2018-2023)
11.8.5 Medical Information Technology, Inc. Recent Development
11.9 Sonde Health, Inc.
11.9.1 Sonde Health, Inc. Company Detail
11.9.2 Sonde Health, Inc. Business Overview
11.9.3 Sonde Health, Inc. Speech Biomarkers Introduction
11.9.4 Sonde Health, Inc. Revenue in Speech Biomarkers Business (2018-2023)
11.9.5 Sonde Health, Inc. Recent Development
11.10 PureTech Health Plc
11.10.1 PureTech Health Plc Company Detail
11.10.2 PureTech Health Plc Business Overview
11.10.3 PureTech Health Plc Speech Biomarkers Introduction
11.10.4 PureTech Health Plc Revenue in Speech Biomarkers Business (2018-2023)
11.10.5 PureTech Health Plc Recent Development
11.11 Orbita Inc.
11.11.1 Orbita Inc. Company Detail
11.11.2 Orbita Inc. Business Overview
11.11.3 Orbita Inc. Speech Biomarkers Introduction
11.11.4 Orbita Inc. Revenue in Speech Biomarkers Business (2018-2023)
11.11.5 Orbita Inc. Recent Development
11.12 MediTECH Electronic GmbH
11.12.1 MediTECH Electronic GmbH Company Detail
11.12.2 MediTECH Electronic GmbH Business Overview
11.12.3 MediTECH Electronic GmbH Speech Biomarkers Introduction
11.12.4 MediTECH Electronic GmbH Revenue in Speech Biomarkers Business (2018-2023)
11.12.5 MediTECH Electronic GmbH Recent Development
11.13 Kintsugi Mindful Wellness
11.13.1 Kintsugi Mindful Wellness Company Detail
11.13.2 Kintsugi Mindful Wellness Business Overview
11.13.3 Kintsugi Mindful Wellness Speech Biomarkers Introduction
11.13.4 Kintsugi Mindful Wellness Revenue in Speech Biomarkers Business (2018-2023)
11.13.5 Kintsugi Mindful Wellness Recent Development
11.14 Ellipsis Health
11.14.1 Ellipsis Health Company Detail
11.14.2 Ellipsis Health Business Overview
11.14.3 Ellipsis Health Speech Biomarkers Introduction
11.14.4 Ellipsis Health Revenue in Speech Biomarkers Business (2018-2023)
11.14.5 Ellipsis Health Recent Development
11.15 Winter Light Labs
11.15.1 Winter Light Labs Company Detail
11.15.2 Winter Light Labs Business Overview
11.15.3 Winter Light Labs Speech Biomarkers Introduction
11.15.4 Winter Light Labs Revenue in Speech Biomarkers Business (2018-2023)
11.15.5 Winter Light Labs Recent Development
11.16 Voice Health Tech
11.16.1 Voice Health Tech Company Detail
11.16.2 Voice Health Tech Business Overview
11.16.3 Voice Health Tech Speech Biomarkers Introduction
11.16.4 Voice Health Tech Revenue in Speech Biomarkers Business (2018-2023)
11.16.5 Voice Health Tech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
